Conference Description

November 19, 2005
Westin Fort Lauderdale
400 Corporate Drive
Ft. Lauderdale, FL 33334
(800) 937-8461

Tell a friend about this conference

Download the brochure for this conference

See how attendees evaluated this conference

CME Credits: 7.0*

Nonrefundable registration fee: $0.

Target Audience: Physicians specializing in cardiology, primary care physicians, cardiology nurse practitioners and physicians assistants.

Program Summary:
The First Annual South Florida Cardiovascular Symposium is a one day program covering recent advances in coronary artery disease risk factor management, cardiovascular imaging, pharmacological and device management of heart failure, and valvular heart disease. It will provide a review of cardiovascular medicine geared to practicing physicians. Nationally known faculty will present evolving issues and challenges relevant to clinical practice. The set of lectures will provide a review of established principles of cardiovascular medicine as well as present new concepts in the advancing field of cardiovascular medicine.

Learning Objectives:
At the conclusion of this program learners should be able to:

1. recognize and discuss the etiology and risk markers of atherogenesis including the role of cholesterol and the metabolic syndrome as well as describe the need for aggressive cholesterol lowering
2. demonstrate that in the management of hypertension, achieving lower blood pressure is the most important factor to prevent cardiovascular events and review the evidence-based data for the current treatment of hypertension
3. summarize clinical data comparing and contrasting the drug eluting stents available in the U.S. and explain the indications and safety issues of drug-eluting stents
4. apply the indications for defibrillator therapy for primary and secondary prevention of sudden cardiac death and for the use of cardiac resynchronization therapy for heart failure
5. review epidemiology of anemia in heart failure and characterize cause and consequences of anemia in heart failure
6. review the epidemiology and pathophysiology of acutely decompensated heart failure and discuss therapeutic approaches to optimization of diuretic therapy
7. recognize pathophysiologic features of aortic and mitral valve disease and understand current recommendations for surgical interventions for aortic and mitral valve disease and the current evidence base supporting these recommendations
8. recognize the emerging potential of CT coronary angiography in the diagnostic and prognostic assessment of CAD

Agenda:

7:30 - 8:10		Continental Breakfast and Registration
8:10 - 8:20		Welcome Remarks Jose R. Soler, MD
8:20 - 9:10		Aggressive Lipid Lowering, Obesity and the Metabolic Syndrome Charles Hennekens, MD
9:10 - 10:00		Hypertension: Update 2005 Robert A. Phillips, MD, PhD
10:00 - 10:20		Exhibits and Break
10:20 - 11:10		Advances in PCI –Drug Eluting Stents Harry Phillips, MD
11:10 - 12:00		Expanding Indications for ICD Therapy in Patients with LV Dysfunction: Painful Lessons from DAVID and Promising New Solutions Thomas A. Burkart, MD, FACC
12:00 - 1:00		Lunch
1:00 - 1:50		New Perspectives on the Management of Acutely Decompensated Heart Failure Stuart David Katz, MD
1:50 - 2:40		Diagnosis and Treatment of Anemia in Heart Failure Stuart David Katz, MD
2:40 - 3:00		Exhibits and Break
3:00 - 4:00		Controversies in the Evaluation and Management of Valvular Heart Disease Robert O. Bonow, MD
4:00 - 5:00		Role of Cardiac CT and CTA in the Evaluation of Coronary Disease Gerald Grubbs, MD
5:00		Closing Remarks Jose R. Soler, MD

Faculty:
Robert Bonow, MD
Chief, Division of Cardiology
Northwestern University Medical School
Northwestern Memorial Hospital
Co-Director of the Northwestern Cardiovascular Institute

Thomas A. Burkart, MD, FACC
Assistant Professor of Medicine
Electrophysiologist at the University of Florida College of Medicine,
Division of Cardiology in Gainesville, Florida

Gerald Grubbs, MD
Director of Radiology
Axcess Diagnostics
Venice, Florida

Charles Hennekens, MD
Co-Director of Cardiovascular Research at MSMC-MHI
Professor of Medicine & Epidemiology and Public Health
at the University of Miami School of Medicine

Stuart David Katz, MD
Associate Professor of Medicine
Yale University School of Medicine
Director Yale Heart Failure and Heart Transplantation Program

Harry R. Phillips, MD
Professor of Medicine
Duke University Medical Center
Durham, NC

Robert A. Phillips, MD, PhD
Chairman, Department of Medicine
Lenox Hill Hospital
Professor of Medicine, NYU School of Medicine
Associate Editor, Archives

Program Chair: Jose R. Soler, MD, FACC

Activity Director: Alan Goodstat, LCSW

*Continuing Education Information:
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. UMMS is accredited by ACCME to provide continuing medical education for physicians. UMMS designates this continuing medical education activity for 7.0 credit hours in Category I toward the Physicians Recognition Award of the American Medical Association. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 8.4 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244-CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spend in the educational activity.

This program is supported through an unrestricted educational grant from the following companies: Abbott Laboratories, Amgen, AstraZeneca, Bristol-Myers Squibb, Comprehensive Home Care, Cordis, Medtronic, Pfizer, sanofi-aventis, Scios.